These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21216262)

  • 1. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain.
    Tronci V; Balfour DJ
    Behav Brain Res; 2011 Jun; 219(2):354-7. PubMed ID: 21216262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.
    Paterson NE; Semenova S; Gasparini F; Markou A
    Psychopharmacology (Berl); 2003 May; 167(3):257-64. PubMed ID: 12682710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
    Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
    Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
    D'Souza MS; Markou A
    Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine.
    Tronci V; Vronskaya S; Montgomery N; Mura D; Balfour DJ
    Psychopharmacology (Berl); 2010 Jul; 211(1):33-42. PubMed ID: 20422403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors.
    Chau P; Söderpalm B; Ericson M
    Addict Biol; 2011 Oct; 16(4):591-9. PubMed ID: 21790901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake.
    Besheer J; Grondin JJ; Cannady R; Sharko AC; Faccidomo S; Hodge CW
    Biol Psychiatry; 2010 May; 67(9):812-22. PubMed ID: 19897175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine-induced conditioned place preference in rats: sex differences and the role of mGluR5 receptors.
    Yararbas G; Keser A; Kanit L; Pogun S
    Neuropharmacology; 2010 Feb; 58(2):374-82. PubMed ID: 19833142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.
    Schroeder JP; Overstreet DH; Hodge CW
    Psychopharmacology (Berl); 2005 Apr; 179(1):262-70. PubMed ID: 15717208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats.
    Lou ZZ; Chen LH; Liu HF; Ruan LM; Zhou WH
    Acta Pharmacol Sin; 2014 Dec; 35(12):1485-92. PubMed ID: 25399651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.
    Rutten K; Van Der Kam EL; De Vry J; Bruckmann W; Tzschentke TM
    Addict Biol; 2011 Jan; 16(1):108-15. PubMed ID: 20579001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
    Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
    Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism.
    Li X; Peng XQ; Jordan CJ; Li J; Bi GH; He Y; Yang HJ; Zhang HY; Gardner EL; Xi ZX
    Sci Rep; 2018 Feb; 8(1):3686. PubMed ID: 29487381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking.
    Kumaresan V; Yuan M; Yee J; Famous KR; Anderson SM; Schmidt HD; Pierce RC
    Behav Brain Res; 2009 Sep; 202(2):238-44. PubMed ID: 19463707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA; Gasparini F; Markou A
    Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.
    Campbell UC; Lalwani K; Hernandez L; Kinney GG; Conn PJ; Bristow LJ
    Psychopharmacology (Berl); 2004 Sep; 175(3):310-8. PubMed ID: 15024550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.